Press releases and news

Treating chronic pain is one of the greatest medical challenges of our time – and a field that has been waiting for real progress for decades. VERTANICAL was founded with the mission of finally opening up new, effective, and safe treatment options for precisely these patients.
With VER-01, we have reached an important milestone on this path. Here you will find our official press releases, current information, and selected media reports.
Known from
The IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsiderThe IndependantThe GuardianOmrForbesFinancial TimesBusiness PunkTwsjThetimesSzSaReutersHandelsblattBusinessinsider
Frame 2155
09.06.2026
Marketing authorization for Exilby® granted in Germany
Frame 2160
18.05.2026
VER-01: FDA Breakthrough Therapy Designation granted
Vertanical Deutsche Schmerz Palliativtage Frankfurt 2026 (1)
20.03.2026
VERTANICAL at the German Pain and Palliative Care Days in Frankfurt 2026
Bundesgesundheitsministerin Nina Warken Besucht Futrue
10.03.2026
German Minister of Health visits FUTRUE
Chronische Rueckenschmerzen Wall Street Journal Ueber Cannabis
12.01.2026
Wall Street Journal on cannabis as a treatment for chronic lower back pain
Trigger Post Popup Open

Contact

For questions and further information, please contact:
pr@vertanical.com
{Date Here}

{Post Title Here}

{Post Full Content Here}
Pressekontakt: